Rasmussen's Encephalitis Recently Proved to be An Autoimmune Disease

Rasmussen's encephalitis has recently been proved to be an autoimmune disorder by researchers who worked on humanized mice to study the disease.

Highlights:

The current study reveals that chronic focal encephalitis or Rasmussen's encephalitis has autoimmune origins.
Rasmussen's encephalitis is a rare neurological disorder that mostly occurs in children below than ten years old.
The disease usually affects one hemisphere of the brain and causes recurring epileptic seizures.

A team of researchers from Université de Montréal (UdeM) and the CHU Sainte-Justine and Université de Montréal Hospital (CHUM) research centers has recently proven that chronic focal encephalitis or Rasmussen's encephalitis is an autoimmune disease (a disease where the immune system attacks the body). The study was conducted on NSG™ mice, a type of humanized mice; this discovery may soon help treat children with Rasmussen's encephalitis.

"Rasmussen's encephalitis is one of those diseases that are so rare that scientists are unable to find enough patients to study it and conduct clinical trials," Dr. Lionel Carmant explains. "What's more, no animals are known to suffer from it, so researchers can't look there for answers either."

Also, treatments proposed to slow down disease progression in affected children have produced contradictory results, particularly in the long term.

Lionel Carmant and Elie Haddad are professors in the Department of Pediatrics at UdeM and researchers at CHU Sainte-Justine, and together they came up with the idea to use these valuable humanized mice to study chronic focal encephalitis.

Encephalitis - Causes, Symptoms, Diagnosis, Treatment & Prevention
Encephalitis is the inflammation of the brain, mostly caused by viruses. Though rare, it is a serious condition and needs urgent treatment in a hospital.

‘Current study sheds light on the autoimmune origins of chronic focal encephalitis or Rasmussen's encephalitis, a rare inflammatory disorder, by using humanized mice to study the disease.’

Study – using humanized mice to study rare diseases

Humanized mice lack an immune system, and hence are used to study the human immune system and in particular illnesses such as cancer, leukemia, HIV and sometimes specific allergies and inflammatory diseases.
In the current study the scientists introduced immune cells from patients with Rasmussen's encephalitis into the mice; since the mice do not have an immune system, they are unable to reject the cells
The researchers then observed the mice and noticed that they developed violent convulsions and brain necrosis, just like their human counterparts
When they took biopsies of the mice's brains, they noticed the immunological damage of the rodent brains was practically identical to that in human
By this, they proved the disease has immune origins

Autoimmune Disorders - Types - Symptoms - Signs - Diagnosis - Treatment
Autoimmune disorders occur when the immune system fails to recognize the body as ‘self’ and attacks it.

Advantages of using humanized mice to study Rasmussen's encephalitis

Experiments done on humanized mice -

Allow for a more precise diagnosis - this is of great help mainly because there are no biological markers for Rasmussen's encephalitis which mean it is difficult to diagnose the disease in certain children.
Has the possibility of making early diagnoses which will help patients get proper treatment early on - it might then be possible to avoid disease consequences like the cognitive decline and possible brain surgery (hemispherectomy).
Can help test various treatments and determine the best one for each sick child - this can pave the way to 'personalized' or 'precision' medicine."

In fact, the NSG™ mice are going to be used to design a standardized diagnostic protocol in pediatric hospitals and might become patient surrogates for making diagnoses and establishing personalized treatment protocols.

World Encephalitis Day 2018
The World Encephalitis Day is observed on the 22nd of February every year to increase awareness about the condition and raise funds to support affected individuals and research on encephalitis.

Rasmussen's encephalitis

Chronic focal encephalitis, or Rasmussen's encephalitis, was discovered by a neurosurgeon, Théodore Rasmussen who specialized in treating epilepsy. It is a rare (up to two cases of Rasmussen's encephalitis are diagnosed each year in Canada) and devastating inflammatory brain disease that most often develops in children. It is a degenerative affliction with causes unknown and characterized by recurring epileptic seizures that resist conventional antiepileptic treatments.

In more serious cases, the number of seizures can only be reduced by either disconnecting the two hemispheres of the brain or removing one of them and dealing with the neurological consequences. As the disease progresses, it triggers cognitive decline and severe learning disabilities.

References:

Humanized mouse model of Rasmussen’s encephalitis supports the immune-mediated hypothesis - (https://www.jci.org/articles/view/97098)
Hania Kebir, Lionel Carmant et al., "Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis", Journal of Clinical Investigation, April 9, (2018). https://doi.org/10.1172/JCI97098

Source-Medindia

Purple Day of Epilepsy: A Global Initiative
Purple Day is a global initiative to increase public awareness of a common neurological disorder – epilepsy. March 26 is marked as a day to support the cause of epilepsy, host and organize awareness events.